NCT04170595 2021-03-03Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody for InjectionGenor Biopharma Co., Ltd.Phase 1/2 Unknown132 enrolled
NCT03881878 2019-03-21TAHP for Patients With HER2-positive Early Breast Cancer and Subsequent AHP Adjuvant tHerapy After SurgerySamsung Medical CenterPhase 1/2 Unknown67 enrolled